A.M.H. v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:19-op-45052 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1441 Petition for Removal- Product Liability |
| Case Filed: | Feb 08, 2019 |
| Case in other court: | New York Western, 1:18-cv-01018 |
| Last checked: Friday Nov 08, 2019 7:10 PM EST |
|
Defendant
Janssen Pharmaceutica Inc.
|
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
|
Defendant
Purdue Pharma L.P.
|
|
|
Defendant
Purdue Pharma Inc.
|
|
|
Defendant
Purdue Frederick Company, Inc.
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Johnson & Johnson
|
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
|
|
Defendant
Insys Therapeutics Inc.
|
|
|
Defendant
Endo Pharmaceuticals Inc
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
|
|
Defendant
AmerisourceBergen Corporation
|
Represented By
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Plaintiff
A.M.H.
|
Represented By
|
| Docket last updated: 04/08/2019 7:01 PM EDT |
| Friday, September 14, 2018 | ||
| 1 | 1
NOTICE OF REMOVAL by Endo Pharmaceuticals Inc. (Filing fee $ 400 receipt number 0209-3220573) from Supreme Court of the State of New York, Niagara County, case number E165792/2018., filed by Endo Pharmaceuticals Inc..(Rothman, Alan) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Exhibit 1 to Notice of Removal,
|
||
|
Att: 2
Exhibit 2 to Notice of Removal,
|
||
|
Att: 3
Exhibit 3 - State Court Documents,
|
||
|
Att: 4
Civil Cover Sheet
|
||
| 2 | 2
Corporate Disclosure Statement by Endo Pharmaceuticals Inc. identifying Corporate Parent Endo International plc for Endo Pharmaceuticals Inc... (Rothman, Alan) [Transferred from nywd on 2/8/2019.]
|
|
| Tuesday, September 18, 2018 | ||
| Case assigned to Hon. Elizabeth A. Wolford. Notification to Chambers of on-line civil case opening. (SG) [Transferred from nywd on 2/8/2019.] | ||
| AUTOMATIC REFERRAL to Mediation The ADR Plan is available for download at http://www.nywd.uscourts.gov/alternative-dispute-resolution(SG) [Transferred from nywd on 2/8/2019.] | ||
| Notice of Availability of Magistrate Judge: A United States Magistrate of this Court is available to conduct all proceedings in this civil action in accordance with 28 U.S.C. 636c and FRCP 73. The Notice, Consent, and Reference of a Civil Action to a Magistrate Judge form (AO-85) is available for download at http://www.uscourts.gov/services-forms/forms. (SG) [Transferred from nywd on 2/8/2019.] | ||
| Friday, September 21, 2018 | ||
| 3 | 3
MOTION for Extension of Time to File Answer re1 Notice of Removal, Letter Motion by AmerisourceBergen Corporation, Cardinal Health, Inc., McKesson Corporation.(Asfendis, Paul) [Transferred from nywd on 2/8/2019.]
|
|
| 4 | 4
Consent MOTION for Extension of Time to File Answer Manufacturer Defendants Consent Motion for Extension of Time to Respond to Plaintiffs Complaint by Endo Health Solutions Inc., Endo Pharmaceuticals Inc..(Rothman, Alan) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Text of Proposed Order
|
||
| 8 | 8
ORDER granting3 Motion for Extension of Time to Answer. Signed by Hon. Elizabeth A. Wolford on 9/21/18. (SG) [Transferred from nywd on 2/8/2019.]
|
|
| Monday, September 24, 2018 | ||
| ATTENTION CORPORATION PLAINTIFFS/DEFENDANTS: All Corporate Disclosure Statements pursuant to Fed.R.Civ.7.1(b) are to be filed within seven(7) days of this notice. (MD) [Transferred from nywd on 2/8/2019.] | ||
| 5 | 5
MOTION to Remand by A.M.H..(Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Exhibit Affidavit in Support,
|
||
|
Att: 2
Exhibit A,
|
||
|
Att: 3
Exhibit B,
|
||
|
Att: 4
Exhibit C,
|
||
|
Att: 5
Exhibit D,
|
||
|
Att: 6
Exhibit E,
|
||
|
Att: 7
Exhibit F,
|
||
|
Att: 8
Exhibit G,
|
||
|
Att: 9
Exhibit H,
|
||
|
Att: 10
Exhibit I,
|
||
|
Att: 11
Exhibit J,
|
||
|
Att: 12
Memorandum in Support Memo in Support
|
||
| 6 | 6 TEXT ORDER re5 Motion to remand. Responses due on or before October 15, 2018. Replies due on or before October 22, 2018. Upon receipt of all papers the Court will determine if oral argument is necessary and, if so, will inform the parties of the date and time. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 09/24/2018. (CDH) [Transferred from nywd on 2/8/2019.] | |
| 7 | 7
AFFIDAVIT of Service for Notice of Motion, Affirmation in Support and Memo of Law served on All defense counsel on 09/24/2018, filed by A.M.H.. (Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
| Tuesday, September 25, 2018 | ||
| 9 | 9
Corporate Disclosure Statement by AmerisourceBergen Corporation identifying Corporate Parent Walgreens Boots Alliance Holdings LLC for AmerisourceBergen Corporation.. (Asfendis, Paul) [Transferred from nywd on 2/8/2019.]
|
|
| Wednesday, September 26, 2018 | ||
| 10 | 10 TEXT ORDER granting4 Consent Motion for Extension of Time to File Answer. The moving parties' deadline to answer or otherwise respond to the Complaint is extended to the later of 30 days after (1) the Court's ruling on the pending motion to remand or (2) the entry of a decision by the Judicial Panel on Multidistict Litigation granting a motion to vacate a conditional transfer order covering this action (or otherwise finally denying transfer of this action to the multi-district litigation). SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 09/26/2018. (CDH) [Transferred from nywd on 2/8/2019.] | |
| Thursday, September 27, 2018 | ||
| 11 | 11
Corporate Disclosure Statement by Purdue Pharma L.P., Purdue Pharma, Inc., The Purdue Frederick Company, Inc. identifying Corporate Parent Pharmaceutical Research Associates, Inc. for The Purdue Frederick Company, Inc.; Corporate Parent No Parent Corporation for Purdue Pharma L.P., Purdue Pharma, Inc... (Cusker Gonzalez, Mara) [Transferred from nywd on 2/8/2019.]
|
|
| Friday, September 28, 2018 | ||
| 12 | 12
Corporate Disclosure Statement by Endo Health Solutions Inc. identifying Corporate Parent Endo International plc for Endo Health Solutions Inc... (Rothman, Alan) [Transferred from nywd on 2/8/2019.]
|
|
| Monday, October 01, 2018 | ||
| 13 | 13
MOTION for Victor Cobb to appear pro hac vice by A.M.H.(SG) [Transferred from nywd on 2/8/2019.]
|
|
| 14 | 14
MOTION for Stephen Wussow to appear pro hac vice by A.M.H.(SG) [Transferred from nywd on 2/8/2019.]
|
|
| 15 | 15
MOTION for Celeste Brustowicz to appear pro hac vice by A.M.H.(SG) [Transferred from nywd on 2/8/2019.]
|
|
| Wednesday, October 03, 2018 | ||
| Verified admissions to the Louisiana State Bar for Attorneys Victor Cobb, Stephen Wussow, and Celeste Brustowicz. (NRE) [Transferred from nywd on 2/8/2019.] | ||
| Tuesday, October 09, 2018 | ||
| Pro Hac Vice fee: for Victor Cobb, Stephen Wussow and Celeste Brustowicz, $450.00, receipt number 61727 (SG) [Transferred from nywd on 2/8/2019.] | ||
| 16 | 16 TEXT ORDER granting13 Motion to Appear Pro Hac Vice by Victor Cobb;14 Motion to Appear Pro Hac Vice by Stephen Wussow;15 Motion to Appear Pro Hac Vice by Celeste Brustowicz. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 10/09/2018. (CDH). -CLERK TO FOLLOW UP- [Transferred from nywd on 2/8/2019.] | |
| Monday, October 15, 2018 | ||
| 17 | 17
25
pgs
MEMORANDUM in Opposition re5 MOTION to Remand filed by Endo Pharmaceuticals Inc.. (Rothman, Alan) [Transferred from nywd on 2/8/2019.]
|
|
| Monday, October 22, 2018 | ||
| 18 | 18
REPLY to Response to Motion re5 MOTION to Remand filed by A.M.H.. (Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
| 19 | 19
*Disregard - Document re-filed at #20 with all attachments* First MOTION to Strike17 Memorandum in Opposition to Motion seeking relief of stay by A.M.H..(Creadore, Donald) Modified on 10/22/2018 (KLH). [Transferred from nywd on 2/8/2019.]
|
|
| 20 | 20
MOTION to Strike17 Memorandum in Opposition to Motion to the extent that Endo seeks court relief in the form of a stay by A.M.H..(Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Affidavit,
|
||
|
Att: 2
Exhibit,
|
||
|
Att: 3
Exhibit,
|
||
|
Att: 4
Memorandum in Support
|
||
| Monday, October 29, 2018 | ||
| 21 | 21
MOTION for leave to file supplemental material in further support of20 MOTION to Strike by A.M.H..(Creadore, Donald) Modified on 10/30/2018 (SG). [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Affidavit,
|
||
|
Att: 2
Exhibit,
|
||
|
Att: 3
Exhibit
|
||
| Tuesday, October 30, 2018 | ||
| E-Filing Notification: Modified relief re21 MOTION for Leave to File (SG) [Transferred from nywd on 2/8/2019.] | ||
| 22 | 22 TEXT ORDER re20 Motion to Strike,21 Motion for Leave to File Supplemental Material. Responses are due on or before November 20, 2018. Replies are due on or before November 27, 2018. Upon receipt of all papers the Court will determine if oral argument is necessary and, if so, will inform the parties of the date and time. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 10/30/2018.(CDH) [Transferred from nywd on 2/8/2019.] | |
| Friday, November 16, 2018 | ||
| 23 | 23
NOTICE of Appearance by Nicholas Robert Tambone on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.(Tambone, Nicholas) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Certificate of Service Certificate of Service
|
||
| 24 | 24
Corporate Disclosure Statement by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Tambone, Nicholas) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Certificate of Service Certificate of Service
|
||
| 25 | 25
MOTION to Stay by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc..(Tambone, Nicholas) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Memorandum in Support Memorandum of Law in Support,
|
||
|
Att: 2
Declaration Declaration of Nicholas R. Tambone in Support,
|
||
|
Att: 3
Exhibit Exhibit A (Complaint),
|
||
|
Att: 4
Exhibit Exhibit B (MDL Transfer Order),
|
||
|
Att: 5
Exhibit Exhibit C (MDL Conditional Transfer Order),
|
||
|
Att: 6
Exhibit Exhibit D (Plaintiffs' Opposition to Conditional Transfer Order),
|
||
|
Att: 7
Exhibit Exhibit E (Proposed Order),
|
||
|
Att: 8
Certificate of Service Certificate of Service
|
||
| Monday, November 19, 2018 | ||
| 26 | 26 TEXT ORDER re25 Motion to Stay. Responses are due on or before December 10, 2018. Replies are due on or before December 17, 2018. Upon receipt of all papers the Court will determine if oral argument is necessary and, if so, will inform the parties of the date and time. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 11/19/2018. (CDH). [Transferred from nywd on 2/8/2019.] | |
| Tuesday, November 20, 2018 | ||
| 27 | 27
MOTION to appear pro hac vice for Terry M. Henry ( Filing fee $ 150 receipt number 0209-3283232.) by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Tambone, Nicholas) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Declaration of Nicholas R. Tambone,
|
||
|
Att: 2
Exhibit A (Petition for Attorney Admission),
|
||
|
Att: 3
Exhibit B (Admission Sponsor Affidavit),
|
||
|
Att: 4
Exhibit C (Attorney Oath),
|
||
|
Att: 5
Exhibit D (Civility Principles Oath),
|
||
|
Att: 6
Exhibit E (Attorney Database Information Form),
|
||
|
Att: 7
Exhibit F (CM/ECF Registration Form),
|
||
|
Att: 8
Certificate of Service
|
||
| 28 | 28
RESPONSE in Opposition re20 MOTION to Strike17 Memorandum in Opposition to Motion to the extent that Endo seeks court relief in the form of a stay ,21 MOTION for Leave to File (ENDO PHARMACEUTICALS INC.S OPPOSITION TO PLAINTIFFS MOTION TO STRIKE AND MOTION FOR LEAVE TO FILE SUPPLEMENTAL MATERIAL) filed by Endo Pharmaceuticals Inc.. (Rothman, Alan) [Transferred from nywd on 2/8/2019.]
|
|
| Wednesday, November 21, 2018 | ||
| Verified admission to the Pennsylvania State Bar for Attorney Terry M. Henry. (NRE) [Transferred from nywd on 2/8/2019.] | ||
| Monday, November 26, 2018 | ||
| 29 | 29 TEXT ORDER granting27 Motion to Appear Pro Hac Vice. SO ORDERED. Signed by Hon. Elizabeth A. Wolford on 11/26/18. (CDH) -CLERK TO FOLLOW UP- [Transferred from nywd on 2/8/2019.] | |
| Tuesday, November 27, 2018 | ||
| 30 | 30
REPLY to Response to Motion re20 MOTION to Strike17 Memorandum in Opposition to Motion to the extent that Endo seeks court relief in the form of a stay filed by A.M.H.. (Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
| 31 | 31
CERTIFICATE OF SERVICE by A.M.H. (Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
| Monday, December 10, 2018 | ||
| 32 | 32
RESPONSE in Opposition re25 MOTION to Stay filed by A.M.H..(Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Exhibit,
|
||
|
Att: 2
Exhibit,
|
||
|
Att: 3
Exhibit,
|
||
|
Att: 4
Exhibit,
|
||
|
Att: 5
Exhibit,
|
||
|
Att: 6
Exhibit,
|
||
|
Att: 7
Exhibit,
|
||
|
Att: 8
Exhibit,
|
||
|
Att: 9
Exhibit,
|
||
|
Att: 10
Exhibit
|
||
| 33 | 33
17
pgs
MEMORANDUM in Opposition re25 MOTION to Stay filed by A.M.H.. (Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
| Tuesday, December 11, 2018 | ||
| 34 | 34
CERTIFICATE OF SERVICE by A.M.H. of affirmation in opposition, with exhibits, together with opposing memorandum of law (Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
| Wednesday, December 12, 2018 | ||
| E-Filing Notification: Missing case caption and/or case number. Action required: re-file document in proper format (SG) [Transferred from nywd on 2/8/2019.] | ||
| 35 | 35
CERTIFICATE OF SERVICE by A.M.H. re33 Memorandum in Opposition to Motion (Creadore, Donald) [Transferred from nywd on 2/8/2019.]
|
|
| Monday, December 17, 2018 | ||
| 36 | 36
REPLY to Response to Motion re25 MOTION to Stay filed by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Janssen Pharmaceutica Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc..(Tambone, Nicholas) [Transferred from nywd on 2/8/2019.]
|
|
|
Att: 1
Declaration of Nicholas R. Tambone in Further Support of Motion to Stay,
|
||
|
Att: 2
Exhibit A (Dec. 13, 2018 JPML Notice of Hearing Session),
|
||
|
Att: 3
Exhibit B (Dec. 6, 2018 Order Denying Transfer),
|
||
|
Att: 4
Exhibit C (Oct. 5, 2018 Report and Recommendation),
|
||
|
Att: 5
Exhibit D (Dec. 14, 2018 Order),
|
||
|
Att: 6
Exhibit E (Dec. 5, 2017 JPML Order),
|
||
|
Att: 7
Certificate of Service
|
||
| Friday, February 08, 2019 | ||
| 37 | 37
MULTIDISTRICT CONDITIONAL LITIGATION TRANSFER ORDER transferring the action to the Northern District of Ohio Signed by Sarah S. Vance on 2/7/19. (MD) [Transferred from nywd on 2/8/2019.]
|
|
| 38 | 38
CASE TRANSFERRED IN from District of New York Western. Case number 1:18-cv-01018. Original file, certified copy of transfer order and docket sheet received.
|
|